Vitamin B12 Shows Potential in Addressing Rare Genetic Disorder Mechanisms in Laboratory Study
Recent research using laboratory models indicates that vitamin B12 can correct metabolic disruptions linked to Verheij syndrome, pointing toward potential new avenues for investigating rare genetic conditions.
🧠AI AnalysisPhoto: ScienceDaily Nutrition
Key points
- Vitamin B12 corrected developmental and metabolic defects in roundworms with a Verheij syndrome mutation.
- Human blood samples and cell datasets showed similar metabolic changes, suggesting common pathways.
- Further clinical research is necessary to confirm if these findings can lead to treatments for patients.
Researchers investigating cellular mechanisms have found that vitamin B12 may reverse developmental abnormalities tied to a rare genetic condition known as Verheij syndrome. The investigation centered on RNA splicing, a vital cellular process that prepares genetic instructions for protein production. When mutations occur in genes responsible for this process, essential functions can be disrupted, leading to developmental delays and restricted growth characteristic of Verheij syndrome.
During laboratory experiments using C. elegans roundworms carrying a similar genetic mutation, scientists observed marked growth delays and smaller body sizes. Further metabolic analysis revealed that the mutation specifically impaired pathways dependent on vitamin B12. When the investigators introduced supplemental vitamin B12 to the model, it restored the disrupted metabolic processes and successfully corrected the developmental defects.
Following these findings, the team examined human cell datasets and blood samples collected from patients with Verheij syndrome with the assistance of neuropediatrician Hormos Dafsari of the University Hospital Cologne. These evaluations indicated parallel metabolic shifts in humans, suggesting shared pathways between the animal models and patients. Led by senior author Adam Antebi of the Max Planck Institute for Biology of Ageing, the research team emphasizes that additional clinical studies are required to determine whether vitamin B12 supplementation can yield therapeutic benefits in humans.
What to know: While laboratory models showed that vitamin B12 corrected developmental defects linked to a Verheij syndrome mutation, researchers have not yet tested or proven whether these findings translate to effective treatments in humans. Always consult a qualified healthcare professional before making changes to supplement regimens or medical care.
Source ScienceDaily Nutrition — sciencedaily.com/releases/2026/11/261115085552.htm ↗
Read next
🏃FitnessUnderstanding and Addressing Love Handles Through Lifestyle Changes
Experts clarify that spot reduction of fat is not physiologically possible, recommending a combination of calorie management and high-intensity interval training instead.
🏃FitnessCiele Releases New Woolmark-Certified Merino Winter Running Apparel
Montreal-based brand Ciele has launched its second collection of merino wool running gear, featuring performance-focused fabrics designed for cold-weather training.
🏥Public HealthPreventive Services Task Force Resumes Meetings Under New Leadership
The U.S. Preventive Services Task Force is set to reconvene this week for the first time in over a year following a significant membership overhaul by Health Secretary Ro…
❤️Conditions & CareBlood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma
Researchers have identified a specific RNA signature in blood plasma that may help predict how well lymphoma patients respond to CAR T-cell therapy.
🧠Mind & Mental HealthAddressing Body Image and the Reality of Gluteal Anatomy
A personal reflection on the social and psychological impact of body shape, specifically regarding the gluteal region, and the limitations of consumer solutions for perce…
❤️Conditions & CareMigraine and Smoking Linked to Increased Early Stroke Risk in Women
A large-scale study suggests that people who have given birth and experience migraines while also smoking face a significantly higher risk of stroke before age 60.